作者: Claudia Vellozzi , Risha Irvin , Andrew Aronsohn , Alexander J Millman , John D Scott
DOI:
关键词:
摘要: Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier treating patients infected with C. This case series demonstrates challenges experienced by and practitioners in accessing these highlights several strategies for navigating the treatment preauthorization process.